# CORT (Corcept Therapeutics Inc.) - SEC EDGAR Financial Statements

> Corcept Therapeutics Inc. reported $963.6M in revenue and net income of $162.3M for the trailing twelve months ended September 30, 2026 (up 64.0% year over year), with a 98.5% gross margin and a 11.5% operating margin.

- Canonical: https://convexityos.com/fundamentals/CORT
- Markdown: https://convexityos.com/fundamentals/CORT.md
- SEC CIK: 0001088856
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:11 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001088856&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $963.6M | +64.0% YoY |
| Operating Income | TTM | $110.9M | 11.5% margin |
| Net Income | TTM | $162.3M | 16.8% net margin |
| Diluted EPS | TTM | $1.32 | Split-adjusted |
| Free Cash Flow | TTM | $194.6M | 20.2% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $370.7M | Total debt: $8.99M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $761.4M | $675.0M | $482.4M | $401.9M | $366.0M | $353.9M | $306.5M | $251.2M | $159.2M | $81.32M |
| Cost of Revenue | $12.98M | $10.88M | $6.48M | $5.38M | $5.28M | $5.58M | $5.50M | $5.21M | $3.55M | $2.06M |
| **Gross Profit** | $748.4M | $664.2M | $475.9M | $396.5M | $360.7M | $348.3M | $301.0M | $246.0M | $155.6M | $79.26M |
| Research & Development | $254.9M | $246.9M | $184.4M | $131.0M | $113.9M | $114.8M | $89.02M | $75.25M | $40.38M | $23.84M |
| Selling, General & Admin | $448.7M | $280.3M | $184.3M | $152.8M | $122.4M | $105.3M | $100.4M | $81.29M | $62.42M | $45.24M |
| **Operating Income** | $44.80M | $137.0M | $107.3M | $112.6M | $124.5M | $128.2M | $111.6M | $89.50M | $52.85M | $10.18M |
| **EBITDA** | $45.95M | $137.7M | $108.3M | $113.9M | $125.5M | $128.7M | $112.3M | $89.73M | $52.96M | $10.27M |
| Interest Expense | -- | -- | -- | -- | -- | -- | -- | -- | -- | $2.04M |
| Income Before Tax | $66.46M | $161.5M | $124.6M | $116.2M | $125.0M | $131.6M | $116.7M | $92.15M | $52.81M | $8.14M |
| Income Tax Expense | -$33.19M | $20.28M | $18.42M | $14.77M | $12.49M | $25.59M | $22.50M | $16.74M | -$76.32M | $0 |
| **Net Income** | $99.65M | $141.2M | $106.1M | $101.4M | $112.5M | $106.0M | $94.18M | $75.41M | $129.1M | $8.14M |
| Basic EPS | $0.95 | $1.35 | $1.02 | $0.95 | $0.97 | $0.92 | $0.82 | $0.65 | $1.14 | $0.07 |
| **Diluted EPS** | $0.82 | $1.23 | $0.94 | $0.87 | $0.89 | $0.85 | $0.77 | $0.60 | $1.04 | $0.07 |
| Basic Shares Outstanding | 103.9M | 103.2M | 103.6M | 106.8M | 115.7M | 115.4M | 114.3M | 115.3M | 113.5M | 110.6M |
| Diluted Shares Outstanding | 120.0M | 113.5M | 111.7M | 116.0M | 126.0M | 124.2M | 122.6M | 126.7M | 124.5M | 116.1M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $340.5M | $256.1M | $164.9M | $202.1M | $207.6M | $194.4M | $157.2M | $181.9M |
| Cost of Revenue | $4.61M | $4.06M | $2.88M | $2.54M | $4.60M | $3.43M | $2.40M | $2.96M |
| **Gross Profit** | $335.9M | $252.1M | $162.0M | $199.6M | $203.0M | $191.0M | $154.8M | $178.9M |
| Research & Development | $56.71M | $53.89M | $66.27M | $64.86M | $68.85M | $60.47M | $60.73M | $70.30M |
| Selling, General & Admin | $164.4M | $156.9M | $145.4M | $130.2M | $124.0M | $103.9M | $90.66M | $83.37M |
| **Operating Income** | $114.7M | $41.30M | -$49.60M | $4.49M | $10.22M | $26.68M | $3.42M | $25.26M |
| **EBITDA** | $115.8M | $42.16M | -$49.00M | $4.23M | $10.70M | $27.14M | $3.88M | $25.54M |
| Income Before Tax | $120.3M | $45.93M | -$44.72M | $9.91M | $15.24M | $31.69M | $9.62M | $31.96M |
| Income Tax Expense | -$6.47M | $2.94M | -$12.95M | -$14.38M | -$4.42M | -$3.46M | -$10.93M | $1.21M |
| **Net Income** | $126.8M | $42.99M | -$31.76M | $24.29M | $19.67M | $35.15M | $20.55M | $30.75M |
| Basic EPS | $1.17 | $0.40 | -$0.30 | -- | $0.19 | $0.33 | $0.19 | -- |
| **Diluted EPS** | $1.01 | $0.36 | -$0.30 | -- | $0.16 | $0.29 | $0.17 | -- |
| Basic Shares Outstanding | 106.6M | 105.4M | 104.4M | -- | 103.5M | 104.1M | 104.1M | -- |
| Diluted Shares Outstanding | 123.2M | 118.4M | 104.4M | -- | 119.4M | 120.5M | 119.8M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $120.5M | $127.7M | $135.6M | $66.33M | $77.62M | $76.19M | $31.27M | $41.62M | $31.06M | $51.54M |
| Short-Term Investments | $251.7M | $255.7M | $232.7M | $365.3M | $145.9M | $364.5M | $244.7M | $165.1M | $57.68M | $0 |
| **Cash & Short-Term Investments** | $372.2M | $383.3M | $368.2M | $431.7M | $223.5M | $440.7M | $276.0M | $206.8M | $88.74M | $51.54M |
| Accounts Receivable, Net | $59.79M | $53.98M | $41.12M | $31.06M | $27.62M | $26.20M | $19.93M | $17.59M | $15.30M | $9.86M |
| Inventory | $12.87M | $12.41M | $7.73M | $6.10M | $4.99M | $4.91M | $5.42M | $4.73M | $4.58M | $2.33M |
| Other Current Assets | $7.10M | $6.08M | $5.88M | -- | -- | -- | -- | -- | -- | -- |
| **Total Current Assets** | $485.5M | $471.6M | $458.6M | $499.3M | $266.5M | $478.5M | $307.4M | $236.8M | $124.2M | $65.69M |
| Property, Plant & Equipment, Net | $1.89M | $2.69M | $195K | $633K | $1.00M | $1.68M | $1.05M | $655K | $518K | $205K |
| Long-Term Investments | $160.3M | $219.8M | $57.18M | $4.95M | $112.3M | $36.20M | $39.35M | $0 | $15.28M | $0 |
| Other Non-Current Assets | $5.15M | $6.61M | $6.54M | $5.06M | $3.08M | $5.00M | $3.45M | $50K | $50K | $24K |
| **Total Non-Current Assets** | $351.2M | $369.0M | $162.9M | $84.18M | $157.3M | $93.23M | $105.0M | $74.87M | $96.35M | $3.06M |
| **Total Assets** | $836.7M | $840.6M | $621.5M | $583.4M | $423.8M | $571.7M | $412.3M | $311.7M | $220.5M | $68.75M |
| Accounts Payable | $40.44M | $15.38M | $17.40M | $11.98M | $6.91M | $10.55M | $7.54M | $8.27M | $8.58M | $2.29M |
| Short-Term Debt | -- | -- | -- | -- | -- | -- | -- | -- | $0 | $14.66M |
| Deferred Revenue (Current) | -- | -- | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Total Current Liabilities** | $166.1M | $140.8M | $104.5M | $72.49M | $47.54M | $47.49M | $38.84M | $35.57M | $29.57M | $27.37M |
| Long-Term Debt | -- | -- | -- | -- | -- | -- | -- | -- | $0 | $0 |
| **Total Non-Current Liabilities** | $22.76M | $20.19M | $10.31M | $9.10M | $409K | $899K | $2.29M | $239K | $0 | $0 |
| **Total Liabilities** | $188.8M | $161.0M | $114.8M | $81.59M | $47.95M | $48.39M | $41.13M | $35.81M | $29.57M | $27.37M |
| **Total Debt (incl. Leases)** | $6.11M | $6.94M | $151K | $1.14M | $526K | $2.55M | $3.46M | -- | $0 | $14.66M |
| Common Stock | $140K | $136K | $133K | $131K | $127K | $122K | $120K | $117K | $115K | $113K |
| Retained Earnings | $643.4M | $543.7M | $402.5M | $296.4M | $195.0M | $82.46M | -$23.55M | -$117.7M | -$193.1M | -$322.3M |
| Accumulated Other Comp. Income | $2.26M | -$217K | $609K | -$869K | -$227K | $415K | $261K | -$70K | -$75K | $0 |
| **Total Stockholders' Equity** | $647.8M | $679.6M | $506.7M | $501.8M | $375.8M | $523.3M | $371.2M | $275.9M | $191.0M | $41.38M |
| Total Equity | $647.8M | $679.6M | $506.7M | $501.8M | $375.8M | $523.3M | $371.2M | $275.9M | $191.0M | $41.38M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $98.72M | $111.0M | $108.7M | $120.5M | $125.1M | $102.7M | $89.82M | $127.7M |
| Short-Term Investments | $272.0M | $197.2M | $229.4M | $251.7M | $296.5M | $239.5M | $232.9M | $255.7M |
| **Cash & Short-Term Investments** | $370.7M | $308.2M | $338.2M | $372.2M | $421.7M | $342.2M | $322.8M | $383.3M |
| Accounts Receivable, Net | $111.1M | $76.92M | $39.07M | $59.79M | $69.63M | $64.57M | $61.82M | $53.98M |
| Inventory | $11.91M | $13.19M | $12.89M | $12.87M | $12.35M | $12.28M | $14.37M | $12.41M |
| Other Current Assets | $7.21M | $8.36M | $6.38M | $7.10M | $6.00M | $7.47M | $24.87M | $6.08M |
| **Total Current Assets** | $533.9M | $439.7M | $426.0M | $485.5M | $541.1M | $443.1M | $438.5M | $471.6M |
| Property, Plant & Equipment, Net | $4.94M | $5.13M | $3.17M | $1.89M | $2.09M | $2.35M | $2.54M | $2.69M |
| Long-Term Investments | $291.6M | $236.5M | $177.3M | $160.3M | $102.6M | $172.8M | $248.0M | $219.8M |
| Other Non-Current Assets | $2.36M | $2.95M | $5.15M | $5.15M | $8.05M | $8.30M | $6.61M | $6.61M |
| **Total Non-Current Assets** | $500.2M | $449.0M | $388.8M | $351.2M | $282.5M | $358.6M | $408.0M | $369.0M |
| **Total Assets** | $1.03B | $888.7M | $814.9M | $836.7M | $823.6M | $801.7M | $846.5M | $840.6M |
| Accounts Payable | $21.92M | $14.91M | $33.31M | $40.44M | $34.45M | $23.52M | $27.95M | $15.38M |
| **Total Current Liabilities** | $177.7M | $153.8M | $149.2M | $166.1M | $172.3M | $144.7M | $143.1M | $140.8M |
| **Total Non-Current Liabilities** | $22.61M | $29.12M | $27.71M | $22.76M | $19.44M | $21.27M | $20.10M | $20.19M |
| **Total Liabilities** | $200.3M | $182.9M | $176.9M | $188.8M | $191.7M | $165.9M | $163.2M | $161.0M |
| **Total Debt (incl. Leases)** | $8.99M | $9.42M | $9.64M | $6.11M | $6.36M | $6.61M | $6.83M | $6.94M |
| Common Stock | $144K | $142K | -- | $140K | $139K | $138K | -- | $136K |
| Retained Earnings | $781.4M | $654.6M | $611.6M | $643.4M | $619.1M | $599.4M | $564.3M | $543.7M |
| Accumulated Other Comp. Income | -$1.50M | $436K | $918K | $2.26M | $2.34M | $2.29M | $692K | -$217K |
| **Total Stockholders' Equity** | $833.7M | $705.8M | $638.0M | $647.8M | $631.9M | $635.8M | $683.3M | $679.6M |
| Total Equity | $833.7M | $705.8M | $638.0M | $647.8M | $631.9M | $635.8M | $683.3M | $679.6M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | $99.65M | $141.2M | $106.1M | $101.4M | $112.5M | $106.0M | $94.18M | $75.41M | $129.1M | $8.14M |
| Depreciation & Amortization | $1.15M | $795K | $1.04M | $1.26M | $1.07M | $525K | $703K | $236K | $106K | $87K |
| Stock-Based Compensation | $84.50M | $61.35M | $48.94M | $42.44M | $42.93M | $33.54M | $29.31M | $23.75M | $13.36M | $7.06M |
| Change in Receivables | -$5.81M | -$12.85M | -$10.07M | -$3.43M | -$1.43M | -$6.27M | -$2.34M | -$2.29M | -$5.44M | -$3.64M |
| Change in Inventory | -$7.48M | $305K | $1.26M | $1.20M | $3.44M | -$3.51M | -$1.04M | -$7.78M | -$2.26M | -$682K |
| Change in Payables | $25.07M | -$2.02M | $5.42M | $4.76M | -$3.60M | $3.16M | -$735K | -$389K | $6.29M | $965K |
| **Operating Cash Flow** | $142.0M | $198.3M | $126.7M | $120.3M | $167.9M | $152.0M | $136.1M | $115.7M | $60.94M | $18.39M |
| Capital Expenditure | -$211K | -$2.17M | -$139K | -$413K | -$469K | -$1.24M | -$1.09M | -$298K | -$419K | -$194K |
| **Free Cash Flow** | $141.8M | $196.1M | $126.5M | $119.9M | $167.4M | $150.7M | $135.0M | $115.4M | $60.52M | $18.20M |
| Purchases of Investments | -$319.6M | -$588.3M | -$328.7M | -$355.1M | -$312.8M | -$420.1M | -$299.0M | -$233.1M | -$103.0M | $0 |
| Sales & Maturities of Investments | -- | -- | $419.8M | $241.2M | $449.4M | $302.1M | $182.3M | -- | -- | -- |
| **Investing Cash Flow** | $69.76M | -$177.6M | $90.91M | -$114.3M | $136.1M | -$119.3M | -$117.8M | -$90.77M | -$73.46M | -$194K |
| Common Stock Issued | -- | -- | $5.81M | $4.38M | $16.23M | $23.23M | $8.42M | $9.32M | $7.18M | $7.68M |
| Share Repurchases | -$172.9M | -$15.66M | $0 | $0 | -- | -$9.95M | -$30.98M | -$23.66M | $0 | $0 |
| **Financing Cash Flow** | -$220.4M | -$28.35M | -$148.7M | -$17.28M | -$302.6M | $12.21M | -$28.64M | -$14.34M | -$7.95M | -$7.10M |
| **Net Change in Cash** | -$7.17M | -$7.89M | $69.22M | -$11.29M | $1.43M | $44.92M | -$10.36M | $10.56M | -$20.47M | $11.10M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | $126.8M | $42.99M | -$31.76M | $24.29M | $19.67M | $35.15M | $20.55M | $30.75M |
| Depreciation & Amortization | $1.03M | $863K | $598K | -$259K | $477K | $469K | $462K | $281K |
| Stock-Based Compensation | $29.44M | $29.42M | $23.04M | $20.77M | $22.88M | $19.02M | $21.83M | $16.80M |
| Change in Receivables | -$34.14M | -$37.85M | $20.71M | $9.84M | -$5.06M | -$2.75M | -$7.84M | $5.74M |
| Change in Inventory | -$5.06M | -$4.26M | -$3.27M | $483K | -$3.94M | -$4.63M | $605K | -$78K |
| Change in Payables | $7.35M | -$18.24M | -$7.64M | $6.00M | $10.92M | -$4.42M | $12.57M | -$3.11M |
| **Operating Cash Flow** | $142.9M | $33.54M | -$16.77M | $38.45M | $54.48M | $44.30M | $4.77M | $60.06M |
| Capital Expenditure | -$709K | -$2.53M | -$201K | -$50K | $0 | -$57K | -$104K | -$121K |
| **Free Cash Flow** | $142.2M | $31.02M | -$16.97M | $38.40M | $54.48M | $44.24M | $4.67M | $59.94M |
| Purchases of Investments | -$228.3M | -$88.95M | -$52.33M | -$143.8M | -$37.35M | -$23.27M | -$115.1M | -$144.6M |
| **Investing Cash Flow** | -$132.0M | -$29.24M | $4.54M | -$11.84M | $14.64M | $70.13M | -$3.17M | -$64.36M |
| Share Repurchases | -$5.75M | $0 | $0 | $0 | -$42.46M | -$103.0M | -$27.43M | $0 |
| **Financing Cash Flow** | -$23.89M | -$2.04M | $760K | -$31.22M | -$46.41M | -$102.9M | -$39.80M | -$4.56M |
| **Net Change in Cash** | -$12.90M | $2.30M | -$11.76M | -$4.64M | $22.39M | $12.93M | -$37.85M | -$9.62M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 98.3% | 98.4% | 98.7% | 98.7% | 98.6% | 98.4% | 98.2% | 97.9% | 97.8% | 97.5% |
| **Operating Margin** | 5.9% | 20.3% | 22.2% | 28.0% | 34.0% | 36.2% | 36.4% | 35.6% | 33.2% | 12.5% |
| **Net Profit Margin** | 13.1% | 20.9% | 22.0% | 25.2% | 30.7% | 30.0% | 30.7% | 30.0% | 81.1% | 10.0% |
| Return on Equity (ROE) | 15.4% | 20.8% | 20.9% | 20.2% | 29.9% | 20.3% | 25.4% | 27.3% | 67.6% | 19.7% |
| Return on Assets (ROA) | 11.9% | 16.8% | 17.1% | 17.4% | 26.6% | 18.5% | 22.8% | 24.2% | 58.5% | 11.8% |
| Current Ratio | 2.92x | 3.35x | 4.39x | 6.89x | 5.60x | 10.07x | 7.91x | 6.66x | 4.20x | 2.40x |
| Quick Ratio | 2.85x | 3.26x | 4.31x | 6.80x | 5.50x | 9.97x | 7.77x | 6.52x | 4.05x | 2.31x |
| Debt to Equity | 0.01x | 0.01x | 0.00x | 0.00x | 0.00x | 0.00x | 0.01x | -- | 0.00x | 0.35x |
| **Revenue Growth (YoY)** | +12.8% | +39.9% | +20.0% | +9.8% | +3.4% | +15.5% | +22.0% | +57.8% | +95.8% | +61.7% |
| Gross Profit Growth (YoY) | +12.7% | +39.6% | +20.0% | +9.9% | +3.6% | +15.7% | +22.3% | +58.1% | +96.4% | +62.0% |
| Operating Income Growth (YoY) | -67.3% | +27.7% | -4.8% | -9.5% | -2.9% | +14.9% | +24.7% | +69.3% | +419.3% | -- |
| **Net Income Growth (YoY)** | -29.4% | +33.0% | +4.7% | -9.9% | +6.1% | +12.6% | +24.9% | -41.6% | +1486.3% | -- |
| EPS Growth (YoY) | -29.6% | +32.4% | +7.4% | -2.1% | +5.4% | +12.2% | +26.2% | -43.0% | +1528.6% | -- |
| Operating Cash Flow Growth (YoY) | -28.4% | +56.5% | +5.3% | -28.3% | +10.5% | +11.6% | +17.7% | +89.8% | +231.3% | +487.6% |
| Free Cash Flow Growth (YoY) | -27.7% | +55.0% | +5.5% | -28.4% | +11.1% | +11.6% | +17.0% | +90.6% | +232.6% | +484.5% |
| 5Y Revenue / Share Growth | +139.1% | +144.0% | +113.8% | +168.4% | +330.2% | +551.7% | +919.4% | +1999.4% | +3844.3% | -- |
| 10Y Revenue / Share Growth | +1458.2% | +2386.9% | +4389.2% | +10484.6% | -- | -- | -- | -- | -- | -- |
| 5Y Net Income / Share Growth | +4.5% | +66.1% | +56.8% | -16.5% | +1221.4% | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 98.5% | 98.3% | 98.3% | 98.3% | 98.2% | 98.4% | 98.4% | 98.4% |
| **Operating Margin** | 11.5% | 0.8% | -1.1% | 5.9% | 8.8% | 14.2% | 16.2% | 20.3% |
| **Net Profit Margin** | 16.8% | 6.6% | 6.2% | 13.1% | 14.3% | 18.7% | 19.5% | 20.9% |
| Return on Equity (ROE) | 19.5% | 7.8% | 7.4% | 15.4% | 16.8% | 21.0% | 19.6% | 20.8% |
| Return on Assets (ROA) | 15.7% | 6.2% | 5.8% | 11.9% | 12.9% | 16.7% | 15.8% | 16.8% |
| Current Ratio | 3.00x | 2.86x | 2.86x | 2.92x | 3.14x | 3.06x | 3.07x | 3.35x |
| Quick Ratio | 2.94x | 2.77x | 2.77x | 2.85x | 3.07x | 2.98x | 2.96x | 3.26x |
| Debt to Equity | 0.01x | 0.01x | 0.02x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x |
| **Revenue Growth (YoY)** | +64.0% | +31.7% | +4.9% | +11.1% | +13.7% | +18.7% | +7.1% | +34.3% |
| Gross Profit Growth (YoY) | +65.4% | +32.0% | +4.7% | +11.5% | +13.0% | +18.4% | +7.3% | +34.0% |
| Operating Income Growth (YoY) | +1022.7% | +54.8% | -1552.0% | -82.2% | -78.1% | -25.1% | -88.4% | -20.2% |
| **Net Income Growth (YoY)** | +544.6% | +22.3% | -254.6% | -21.0% | -58.3% | -1.0% | -26.0% | -1.9% |
| EPS Growth (YoY) | +515.8% | +21.2% | -257.9% | -- | -57.8% | -2.9% | -29.6% | -- |
| Operating Cash Flow Growth (YoY) | +162.3% | -24.3% | -451.6% | -36.0% | -25.7% | +7.5% | -79.9% | +986.2% |
| Free Cash Flow Growth (YoY) | +161.0% | -29.9% | -463.8% | -35.9% | -24.0% | +8.5% | -80.4% | +984.0% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
